On Nov 23, 12:12 pm, Paul <p...@hpaulmoon.com> wrote:

I really like their pipeline! Amazing!! If BMR called DNDN this might
be another sure gainer - i think something is brewing from the gains
it made friday - good luck to you.

On Nov 22, 10:02 pm, "MarketM.01" <marketm...@gmail.com> wrote:

On Nov 22, 9:57 pm, SmartTrader123 <smarttrader...@gmail.com> wrote:

Taking economic factors into account & with gold prices rising steady
& the logistics of the property, (MASP) feels this property warrants
becoming their number one focus.

3 wells in the Canadian Basin have generated {$17 Million USD} in
revenue or a projected {$230 Million USD} / year. The commercial wells
have Produced a total amount of 236625 barrels with an average daily
production rate of 4584 barrels/ day. All assets yield a total daily
production rate of 25000 barrels / day.

www.masspetroleum.com

MASS Petroleum, Inc. Ticker symbol is MASP, Google finance has been
advised that the ticker symbol MASPE is invalid & that updates be made
as soon as possible. You can visit www.pinksheets.com for all the
current Charts / Press Releases / Company info.

BZCN offers liqiudation for Ebay.  They pick up products sell them on
Ebay for a lot more then they paid for it.  They have also opened
another clothing store called Luckys 7 in California that sell
brandname clothes for less.  Kind of like Ross.

BZCN has positive feed back and is begining to make money.  This
holiday season many people are trying to save money and BZCN does just
that.  BZCN helps companies save money, time and wearhouse space.  In
these difficult time saving money is a key point to get through this
recession.  Do a little DD before you buy this but I think you will
find this stock has some huge potential and is about to start a nicve
run in a short period of time.

Our Exploding New Pick is Vivakor, Inc. VIVK http://www.vivakor.com/

VIVK is a trans-disciplinary biomedical/biotechnology company involved
in Discovering, Developing and Commercializing Solutions that
positively impact life. www.vivakor.com

VIVK plans to adapt a $300 Million potential technology upgrade to
produce and enhance MRI images which might improve MRI resolution
along with providing additional data such a blood flow velocity in
images tissues.

Market potential of about $15 Million just within 12 month
commercialization of the electro-optical devices released by VIVK.

VIVK have a fully integrated specialist team working on clinical trial
on Digital Photo screener, Opti-Ear and Anemia Monitor, having a
completion time of late 2009, positive results may drastically reduce
overall time and cost from previously used technology.

Experienced BOD Matthew Nicosia, Dr.Tannin Fuju and John Grayga have
strategically grown the revenue of VIVK from $20 Million to $120
Million. They approved a dividend to every share holders. Each share
holder will receive one HealthAmerica share for every share of Vivakor
Inc.

VIVK is currently in collaboration with University of IOWA, developing
a digital photo refractor that is intended to modernize child vision
screening. Approval has been granted from Western Institutional Review
Borad(20080731) to conduct human validation study.

VIVK has developed a series of nutraceutical formulations, including
VivaBlend, and plan to develop additional nutraceuticals, botanicals
and supplements. VIVK recently received 25000 units purchase order for
one of their products.

Critical advancement in the biological sample preservation are also
been evolved in VIVK. They have developed specialized Cryovials that
accommodate an improved method of cryopreservation of cells, blood and
other bio-materials.

VIVK have recently launched its sales products to Exploding Indian
Biotech market. Biopharma remains India’s biggest sector, accounting
for nearly 70% of the total revenues, expected to be worth US $5.7
Billion by 2012-2013. The future of the bio-supplier industry in India
looks very bright and so does of VIVK.

Check out Complete Presentation only at www.stockexploder.com

Please do your own due diligence on VIVK
All The Best

Exploder

www.stockexploder.com

 *Never invest in a stock mentioned by stockexploder.com unless you
can afford to lose your entire investment. For full disclaimer
http://www.stockexploder.com/disclaimer.html

MASP is at 52-week lows, it seems like it has pretty much bottomed out
& is ripe & ready for a bounce.

MASP is definitely set to profit from rising oil prices, they are near
52-week highs right now, and many analysts are predicting over $90 /
barrel by year-end

MASP recently announced that it has secured current working Oil / Gas
& Mineral resources valued at {$400 Million USD} in the Canadian Basin
area. The approval is huge as it shows that WallStreet is embracing
the company's tremendous potential.

This is fantastic news, showing first and foremost that MASP does
indeed have new locations that it wishes to exploit, & also that big
investment firms are embracing the company's potential.

So who is MASP exactly? MASP is an independant energy company that
deals with valuable Oil / Gas & Mineral resources in  North America &
Russia. MASP identifies abandoned Oil / Gas & Mineral assets & brings
them back to life through revolutionary recompletion & work-over
activities.

This allows MASP to exploit low risk, proven reserves that could still
hold an incredible amount of Oil / Gas & Mineral resources.

MASP saves the incredibly high costs of initial drilling (since the
wells were already being exploited in the past), and therefore MASP's
assets & cash flows are able to increase without the big risk, & big
initial investment of typical drilling projects.

Imagine a company that can reap the incredible profits from Oil / Gas
& Mineral resources, but that doesn't need to spend the millions to do
so! MASP is that amazing company!

MASP currently has several properties that they are working on &
constantly profiting from, as well as many more that they are
researching including Oil / Gas & Mineral resources in the Perm region
of Russia valued at (200 Million USD). A Press release is expected
confirming the approval at any moment.

Photos and more information on each of the wells can be found online
on MASP's website, it's definitely worth a look! www.masspetroleum.com

MASP received a $0.92 target from trusted research firm GrassRoots!
MASP is currently in the 0.025 range, & should it hit the 0.92 target,
that would represent a gain of 3680% !

These are the kind of gains we strive to bring you. It seems like the
stars are lining up for MASP with big support from the financing
company, GrassRoots Research, and now us!

Our last 3 picks jumped 500%, 2550% and 100%. We are now confident
that MASP could be our next pick to explode! Make sure to add MASP to
your watchlist and follow it closely starting today!

Happy Trading,

Power3 Medical is a breakthrough proteomics company specializing in
the identification of disease footprints in the areas of
chemotherapeutic drug resistance and the early detection of breast
cancer and neurological diseases opposed to late stage detection.

They have recently filed for 3 utility patents due to their advances
in early stage breast canc
 Proteomics is the study and analysis of proteins, the fundamental
building blocks of the human body. By studying proteins, scientists
can understand more fully the functioning of a healthy body and
identify the proteins associated with specific diseases. Proteins are
not only the building blocks for life; in them, evidence can be found
for serious diseases such as cancer, neurodegenerative disease
     * Breast Cancer
    * Alzheimer’s Disease
    * ALS (Lou Gehrig’s Disease)
    * Parkinson’s Disease
    * Leukemia
    * Gastrointestinal Disease
    * Metabolic Syndrome
    * Chemotherapeutic Drug Resistance

 These discovered and patent-pending biomarkers solve critical
challenges facing pharmaceutical and diagnostic companies and are
currently being used to design tests to diagnose diseases and discover
targets for new drugs to treat the diseases.

Each validated biomarker, pattern, new diagnostic test, or drug
target, may have a potential market value from $10 – $100 million plus

RECENT NEWS:

 PWRM Announced that its Chief Scientific Officer is Chair and Keynote
Speaker of Session at the BTI Life Sciences 2nd Annual Congress and
Expo of Molecular Diagnostics in Beijing, China in November 2009

Further international recognition of validity as the company’s
President and CSO, Dr. Ira Goldknopf will deliver an invited Keynote
address and chair a session on “Biomarkers and Diagnostics in
Personalized Medicine (Track 6-4),” at the BIT Life Sciences 2nd
International Congress and Expo of Molecular Diagnostics in Beijing,
China, November 19-21, 2009. The Theme of the meeting is “New
Leadership

www.pickthatakecents.com

Free trial no credit card needed

We don't need to hype it, our picks take care of that.

www.masspetroleum.com
www.pinksheets.com

SNBP is our New Pick www.sinobiopharma.com

SINO BIOPHARMA SNBP a Fully integrated specality biopharmaceutical
company with 30,000 sq.meter Certified Production Facilities in China.

Estimated Chinese Health Care Market Demand of $600 Billion by 2015.We
all are aware China’s Current population is 1.4 Billion.

SNBP traded as high as $2.0 in the PAST, we can shoot for a gain of
8400%

Leadership of CEO Dr. Lequn Lee Huang a former manager of the Bayer
Co., one of the world's largest pharmaceutical companies and CFO Mr.
Dong Ying formerly of JP Morgan Chase.

SNBP Anesthetics Projected sale of 1.5 million units and 500,000
tablets for cardiovascular diseases in 2009.

Key Drives:
Outstanding financial results; more than 2000% growth in 3 years.
4 key marketed products; multiple products in pipeline.
R&D Partnership with Cornell University and 3 Top Universities in
China.
Established Nation wide Sales and Marketing Network in China.
Aging Population & Increasing Life Style diseases.
Improving Health Insurance Programs and Coverage.

PLAN FOR FUTURE: Sinobiopharma has a clearly defined strategy to drive
short, middle and long term growth.  All drug development will
leverage the Company's patented technology for fast, low-cost drug
synthesis and new technology for formulation.

Check out Complete Presentation only at www.stockexploder.com
Please do your own due diligence on SNBP
All The Best

Exploder

www.stockexploder.com
 *Never invest in a stock mentioned by stockexploder.com unless you
can afford to lose your entire investment. For full disclaimer
http://www.stockexploder.com/disclaimer.html